203 related articles for article (PubMed ID: 23894402)
1. Structural and functional perturbation of Giardia lamblia triosephosphate isomerase by modification of a non-catalytic, non-conserved region.
Hernández-Alcántara G; Torres-Larios A; Enríquez-Flores S; García-Torres I; Castillo-Villanueva A; Méndez ST; de la Mora-de la Mora I; Gómez-Manzo S; Torres-Arroyo A; López-Velázquez G; Reyes-Vivas H; Oria-Hernández J
PLoS One; 2013; 8(7):e69031. PubMed ID: 23894402
[TBL] [Abstract][Full Text] [Related]
2. Disulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential.
Castillo-Villanueva A; Rufino-González Y; Méndez ST; Torres-Arroyo A; Ponce-Macotela M; Martínez-Gordillo MN; Reyes-Vivas H; Oria-Hernández J
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):425-432. PubMed ID: 29197728
[TBL] [Abstract][Full Text] [Related]
3. Determining the molecular mechanism of inactivation by chemical modification of triosephosphate isomerase from the human parasite Giardia lamblia: a study for antiparasitic drug design.
Enríquez-Flores S; Rodríguez-Romero A; Hernández-Alcántara G; Oria-Hernández J; Gutiérrez-Castrellón P; Pérez-Hernández G; de la Mora-de la Mora I; Castillo-Villanueva A; García-Torres I; Méndez ST; Gómez-Manzo S; Torres-Arroyo A; López-Velázquez G; Reyes-Vivas H
Proteins; 2011 Sep; 79(9):2711-24. PubMed ID: 21786322
[TBL] [Abstract][Full Text] [Related]
4. Disulfide bridges in the mesophilic triosephosphate isomerase from Giardia lamblia are related to oligomerization and activity.
Reyes-Vivas H; Diaz A; Peon J; Mendoza-Hernandez G; Hernandez-Alcantara G; De la Mora-De la Mora I; Enriquez-Flores S; Dominguez-Ramirez L; Lopez-Velazquez G
J Mol Biol; 2007 Jan; 365(3):752-63. PubMed ID: 17095008
[TBL] [Abstract][Full Text] [Related]
5. Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.
Reyes-Vivas H; de la Mora-de la Mora I; Castillo-Villanueva A; Yépez-Mulia L; Hernández-Alcántara G; Figueroa-Salazar R; García-Torres I; Gómez-Manzo S; Méndez ST; Vanoye-Carlo A; Marcial-Quino J; Torres-Arroyo A; Oria-Hernández J; Gutiérrez-Castrellón P; Enríquez-Flores S; López-Velázquez G
Antimicrob Agents Chemother; 2014 Dec; 58(12):7072-82. PubMed ID: 25223993
[TBL] [Abstract][Full Text] [Related]
6. Species-specific inhibition of Giardia lamblia triosephosphate isomerase by localized perturbation of the homodimer.
Enriquez-Flores S; Rodriguez-Romero A; Hernandez-Alcantara G; De la Mora-De la Mora I; Gutierrez-Castrellon P; Carvajal K; Lopez-Velazquez G; Reyes-Vivas H
Mol Biochem Parasitol; 2008 Feb; 157(2):179-86. PubMed ID: 18077010
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors drastically modify triosephosphate isomerase from Giardia lamblia at functional and structural levels, providing molecular leads in the design of new antigiardiasic drugs.
García-Torres I; de la Mora-de la Mora I; Marcial-Quino J; Gómez-Manzo S; Vanoye-Carlo A; Navarrete-Vázquez G; Colín-Lozano B; Gutiérrez-Castrellón P; Sierra-Palacios E; López-Velázquez G; Enríquez-Flores S
Biochim Biophys Acta; 2016 Jan; 1860(1 Pt A):97-107. PubMed ID: 26518348
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the mechanisms of tryptophan fluorescence quenching in the triosephosphate isomerase from Giardia lamblia.
Hernández-Alcántara G; Rodríguez-Romero A; Reyes-Vivas H; Peon J; Cabrera N; Ortiz C; Enríquez-Flores S; De la Mora-De la Mora I; López-Velázquez G
Biochim Biophys Acta; 2008 Nov; 1784(11):1493-500. PubMed ID: 18620084
[TBL] [Abstract][Full Text] [Related]
9. An unusual triosephosphate isomerase from the early divergent eukaryote Giardia lamblia.
López-Velázquez G; Molina-Ortiz D; Cabrera N; Hernández-Alcántara G; Peon-Peralta J; Yépez-Mulia L; Pérez-Montfort R; Reyes-Vivas H
Proteins; 2004 Jun; 55(4):824-34. PubMed ID: 15146481
[TBL] [Abstract][Full Text] [Related]
10. Probing the role of highly conserved residues in triosephosphate isomerase--analysis of site specific mutants at positions 64 and 75 in the Plasmodial enzyme.
Bandyopadhyay D; Murthy MR; Balaram H; Balaram P
FEBS J; 2015 Oct; 282(20):3863-82. PubMed ID: 26206206
[TBL] [Abstract][Full Text] [Related]
11. Structural and mutagenesis studies of leishmania triosephosphate isomerase: a point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power.
Williams JC; Zeelen JP; Neubauer G; Vriend G; Backmann J; Michels PA; Lambeir AM; Wierenga RK
Protein Eng; 1999 Mar; 12(3):243-50. PubMed ID: 10235625
[TBL] [Abstract][Full Text] [Related]
12. Structural effects of a dimer interface mutation on catalytic activity of triosephosphate isomerase. The role of conserved residues and complementary mutations.
Banerjee M; Balaram H; Balaram P
FEBS J; 2009 Aug; 276(15):4169-83. PubMed ID: 19583769
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of recombinant human triosephosphate isomerase at 2.8 A resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme.
Mande SC; Mainfroid V; Kalk KH; Goraj K; Martial JA; Hol WG
Protein Sci; 1994 May; 3(5):810-21. PubMed ID: 8061610
[TBL] [Abstract][Full Text] [Related]
14. Different contribution of conserved amino acids to the global properties of triosephosphate isomerases.
Aguirre Y; Cabrera N; Aguirre B; Pérez-Montfort R; Hernandez-Santoyo A; Reyes-Vivas H; Enríquez-Flores S; de Gómez-Puyou MT; Gómez-Puyou A; Sanchez-Ruiz JM; Costas M
Proteins; 2014 Feb; 82(2):323-35. PubMed ID: 23966267
[TBL] [Abstract][Full Text] [Related]
15. Revisiting the mechanism of the triosephosphate isomerase reaction: the role of the fully conserved glutamic acid 97 residue.
Samanta M; Murthy MR; Balaram H; Balaram P
Chembiochem; 2011 Aug; 12(12):1886-96. PubMed ID: 21671330
[TBL] [Abstract][Full Text] [Related]
16. Structural studies show that the A178L mutation in the C-terminal hinge of the catalytic loop-6 of triosephosphate isomerase (TIM) induces a closed-like conformation in dimeric and monomeric TIM.
Alahuhta M; Casteleijn MG; Neubauer P; Wierenga RK
Acta Crystallogr D Biol Crystallogr; 2008 Feb; 64(Pt 2):178-88. PubMed ID: 18219118
[TBL] [Abstract][Full Text] [Related]
17. A guide to the effects of a large portion of the residues of triosephosphate isomerase on catalysis, stability, druggability, and human disease.
Olivares-Illana V; Riveros-Rosas H; Cabrera N; Tuena de Gómez-Puyou M; Pérez-Montfort R; Costas M; Gómez-Puyou A
Proteins; 2017 Jul; 85(7):1190-1211. PubMed ID: 28378917
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into N-terminal to C-terminal interactions and implications for thermostability of a (β/α)8-triosephosphate isomerase barrel enzyme.
Mahanta P; Bhardwaj A; Kumar K; Reddy VS; Ramakumar S
FEBS J; 2015 Sep; 282(18):3543-55. PubMed ID: 26102498
[TBL] [Abstract][Full Text] [Related]
19. Complementation of an Escherichia coli glycolysis mutant by Giardia lamblia triosephosphate isomerase.
Mowatt MR; Weinbach EC; Howard TC; Nash TE
Exp Parasitol; 1994 Feb; 78(1):85-92. PubMed ID: 8299763
[TBL] [Abstract][Full Text] [Related]
20. Triosephosphate isomerase from Plasmodium falciparum: the crystal structure provides insights into antimalarial drug design.
Velanker SS; Ray SS; Gokhale RS; Suma S; Balaram H; Balaram P; Murthy MR
Structure; 1997 Jun; 5(6):751-61. PubMed ID: 9261072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
